Interestingly, breast cancer cells expressing NDRG2 have also inhibited osteoclast differentiation by downregulating secreted ICAM1 expression, suggesting that NDRG2 may suppress bone metastases from breast cancer [74]. This evidence concerns the gene ICAM1 and breast carcinoma.